Compare Hubbell (HUBB) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hubbell vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Hubbell trades at $475.79 (market cap $25.12B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.8 (market cap $6.04B). The key difference: Hubbell is far larger — about 4.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Hubbell pays a 1.19% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 3 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HUBB | IOVA | |
|---|---|---|
Market Cap | $25.12B | $6.04B |
Volume | 784,557 | 14,805,993 |
Sector | Industrials | Health |
52-Week High | $557.85 | $14.82 |
52-Week Low | $407.36 | $1.81 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $30.28B | $5.97B |
Dividend Yield | 1.19% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hubbell
Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.
Read more on HUBB →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
